Showing results (141-150 of 162) with videos related to

Sort By:
Pageof 17
Bioanalysis|August 18, 2020
European Immunogenicity Platform 11th Open Scientific Symposium on immunogenicity of biopharmaceuticalsSophie Tourdot, Carolina B Quaglia, Paul Chamberlain, et al.
International Journal of Radiation Oncology, Biology, Physics|February 16, 1999
Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancerE Touboul, L Buffat, Y Belkacémi, et al.
Frontiers in Immunology|June 17, 2024
Characterization of anti-drug antibody responses to the T-cell engaging bispecific antibody cibisatamab to understand the impact on exposureGregor P Lotz, Achim Lutz, Meret Martin-Facklam, et al.
Bone Marrow Transplantation|August 29, 2007
Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantationsE Foïs, M Desmartin, S Benhamida, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trialB Bui-Nguyen, I Ray-Coquard, C Chevreau, et al.
Bone Marrow Transplantation|February 28, 2006
Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocolJ-P Lotz, P Pautier, F Selle, et al.
Plos One|September 18, 2012
Fragments of HdhQ150 mutant huntingtin form a soluble oligomer pool that declines with aggregate deposition upon agingDavid Marcellin, Dorothee Abramowski, Douglas Young, et al.
Mabs|March 5, 2024
Proceedings of the 14th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticalsSophie Tourdot, Daniel Baltrunkonis, Sofie Denies, et al.
Mabs|November 17, 2022
Enhanced immunogenic potential of cancer immunotherapy antibodies in human IgG1 transgenic miceJerome Egli, Stefan Heiler, Felix Weber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2005
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trialJ-P Lotz, B Bui, F Gomez, et al.
Pageof 17